Cybin Strengthens IP Portfolio By Filing Of 16th Patent Application: Psychedelic Investors React Aug 20, 2021
Cybin Files Two Additional International Patent Applications in Support of the Company’s Research Phase Programs Aug 19, 2021
Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of… May 18, 2021
